Covid19

“COVID-19: Establishing rapid laboratory diagnostics programs in LMICs” is a project coordinated by the ICGEB and implemented in partnership with reference testing laboratories in Africa. We are pleased to present the video of the project.

Amongst its activities with the United Nations, ICGEB links with 2030 CONNECT – a UN online technology platform for the SDGs.

7 April 2021: Published today in Nature, Researchers in London and Trieste discover the mechanism that leads to the fusion of cells infected with Sars-Cov-2 and a drug capable of blocking this process.

17 March 2021: One year into Covid-19, ICGEB Principal Investigators from Trieste, New Delhi, and Cape Town present their research and work in the field at the ICGEB Symposium.

Monday, 1 February 2021, the cooperation project between ICGEB, Trieste and NICOLAE TESTEMITANU SUMPH, Chişinău: “Strengthening epidemiological surveillance capacity to address COVID-19 and other epidemics” commences.

Investigations of deceased COVID-19 patients have shed light on possible lung damage caused by the virus. The latest publication by Mauro Giacca, Serena Zacchigna, and team reports.

MSC Seashore is the first cruise liner to feature this advanced air sanitation technology developed by Fincantieri in cooperation with the ICGEB.

The ICGEB is providing links and publishing updates from its network in Member States on the Covid-19/SARS-CoV-2 actions being undertaken across the globe on this page for reference.

More than 100 COVID-19 research project proposals were submitted in 2020 under the ICGEB CRP Programme call.

A recent scientific collaboration of the Molecular Virology Lab reveals that a physiological derivative of cholesterol blocks the COVID-19 virus, with important implications for COVID-19 therapy.